These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 376043)

  • 1. Controlled trial of cyclophosphamide in active chronic hepatitis.
    Gilmore IT; Cowan RE; Axon AT; Thompson RP; Wheeler MJ
    Br Med J; 1979 Apr; 1(6171):1120-1. PubMed ID: 376043
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled, double-blind, comparative studies of disease modifying anti-rheumatic drugs in the treatment of patients with rheumatoid arthritis. A review.
    Halberg P
    Dan Med Bull; 1984 Oct; 31(5):391-402. PubMed ID: 6391848
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trial with arginine tidiacicate in symptomatic chronic persistent hepatitis.
    Rizzo S
    Int J Clin Pharmacol Res; 1986; 6(3):225-30. PubMed ID: 3527997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Supportive therapy with xenogenous peptides in patients with metastatic breast cancer undergoing aggressive chemotherapy (modified AC-protocol): a prospective, randomized double-blind study].
    Lange OF
    Onkologie; 1987 Jun; 10(3 Suppl):40-3. PubMed ID: 3309762
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of active chronic hepatitis with cyclophosphamide.
    Naccarato R; Farini R; Chiaramonte M; Fagiolo U; Sturniolo GC
    Postgrad Med J; 1974 Jan; 50(579):16-24. PubMed ID: 4464495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide in chronic active hepatitis.
    Althouse R; Huff JE; Tomatis L; Wilbourn JD
    Br Med J; 1979 Jun; 1(6178):1630-1. PubMed ID: 466166
    [No Abstract]   [Full Text] [Related]  

  • 7. Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis.
    Kirk AP; Jain S; Pocock S; Thomas HC; Sherlock S
    Gut; 1980 Jan; 21(1):78-83. PubMed ID: 6988304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of tiopronin on chronic hepatitis: a double-blind clinical study.
    Ichida F; Shibasaki K; Takino T; Suzuki H; Fujisawa K; Inoue K; Hirayama C; Kaito I; Hirasawa T; Kameda H; Inoue J; Satoh G; Kosaka Y; Yamamoto S; Nagashima H; Tsuji T; Ohta Y; Okada J
    J Int Med Res; 1982; 10(5):325-32. PubMed ID: 6128281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic active hepatitis. An analysis of three controlled trials.
    Wright EC; Seeff LB; Berk PD; Jones A; Plotz PH
    Gastroenterology; 1977 Dec; 73(6):1422-30. PubMed ID: 334625
    [No Abstract]   [Full Text] [Related]  

  • 10. Is chronic active hepatitis curable?
    Müting D; Winter G; Fischer R; Kruck P; Kalk H
    Lancet; 1982 Apr; 1(8277):905-6. PubMed ID: 6122118
    [No Abstract]   [Full Text] [Related]  

  • 11. Remission of active chronic hepatitis after treatment with cyclophosphamide and prednisolone. Report of four cases.
    Pengelly CD; Jennings RC
    Practitioner; 1975 Feb; 214(1280):233-42. PubMed ID: 1144250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of (+)-cyanidanol-3 in the treatment of chronic active hepatitis (author's transl)].
    Demeulenaere F; Desmet VJ; Dupont E; Fiasse R; Gisselbrecht H; Heully F; Jeanpierre R; Lecomte J; Lennes G; Macinot C; Migeotte P; Pirotte J; Rauber G; Ruyters L; Van Cauwenberge H
    Gastroenterol Clin Biol; 1981 Mar; 5(3):314-23. PubMed ID: 7014344
    [No Abstract]   [Full Text] [Related]  

  • 13. Arginine thiazolidinecarboxylate in the treatment of chronic active hepatitis: double-blind comparison with placebo.
    Miracco A; Iodice G; Peluso C; Quarentelli A; Selce P; Tedesco A; Pastore P
    J Int Med Res; 1984; 12(1):35-9. PubMed ID: 6363155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis.
    Hallé P; Paré P; Kaptein E; Kanel G; Redeker AG; Reynolds TB
    Gastroenterology; 1982 May; 82(5 Pt 1):925-31. PubMed ID: 7037524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of epomediol in the treatment of hepatopathies: a double-blind multi-centre study.
    Capurso L; Kock M; Ferrario F; Del Sette F; Gramolini C; Castiglioni CL
    J Int Med Res; 1987; 15(3):134-47. PubMed ID: 3301453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective randomized double-blind controlled study of cadaver donor pretreatment with cyclophosphamide in human renal transplantation.
    Chatterjee SN; Smith R; Fine S; Schulman B; Fine RN
    Transplant Proc; 1981 Mar; 13(1 Pt 2):709-11. PubMed ID: 7022938
    [No Abstract]   [Full Text] [Related]  

  • 17. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.
    Lam KC; Lai CL; Trepo C; Wu PC
    N Engl J Med; 1981 Feb; 304(7):380-6. PubMed ID: 7005678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial.
    Porter HP; Simon FR; Pope CE; Volwiler W; Fenster LF
    N Engl J Med; 1971 Jun; 284(24):1350-5. PubMed ID: 4930603
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of hepatitis B virus carriage of infants using HBV vaccine in Shanghai. Preliminary report of a randomized double-blind placebo-controlled trial.
    Xu ZY; Francis DP; Liu CB; Purcell RH; Duan SC; Chen RJ; Wen YM
    Chin Med J (Engl); 1985 Sep; 98(9):623-6. PubMed ID: 3938375
    [No Abstract]   [Full Text] [Related]  

  • 20. Thymostimulin in the treatment of hepatitis B surface antigen-positive chronic active hepatitis. Controlled clinical trial--two years follow-up.
    Romeo F; Palmisano L; Arcoria D
    Arzneimittelforschung; 1987 Apr; 37(4):450-6. PubMed ID: 3300664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.